Manchester Metropolitan University and Astellas Pharma Europe Limited
Lead Participant:
MANCHESTER METROPOLITAN UNIVERSITY
Abstract
To develop effective personalised treatment pathways based on a redesigned NPD process informed by an embedded big data analytics capability and evidence based strategies to improve patient compliance through added value services.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| MANCHESTER METROPOLITAN UNIVERSITY | £221,018 | £ 92,566 |
Participant |
||
| KTN LTD |
People |
ORCID iD |